Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

SPOP mutations promote tumor immune escape in endometrial cancer via the IRF1–PD-L1 axis
Kun Gao, Qing Shi, Ye Gu, et al.
Cell Death and Differentiation (2022) Vol. 30, Iss. 2, pp. 475-487
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
Bo Hou, Ting Chen, He Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 27
The multiple roles of interferon regulatory factor family in health and disease
Luyao Wang, Yanghui Zhu, Nan Zhang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 14
BCLAF1 binds SPOP to stabilize PD-L1 and promotes the development and immune escape of hepatocellular carcinoma
Zongdong Yu, Xiang Wu, Jie Zhu, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 10
Ubiquitination Enzymes in Cancer, Cancer Immune Evasion, and Potential Therapeutic Opportunities
A. Awan, Maryiam Jama Ali Osman, Omar M. Khan
Cells (2025) Vol. 14, Iss. 2, pp. 69-69
Open Access | Times Cited: 1
Baicalin attenuates the immune escape of oral squamous cell carcinoma by reducing lactate accumulation in tumor microenvironment
Yameng Cui, Jingwen Liu, Xi Wang, et al.
Journal of Advanced Research (2025)
Open Access | Times Cited: 1
Roles of Interferon Regulatory Factor 1 in Tumor Progression and Regression: Two Sides of a Coin
Alina M. Perevalova, L. F. Gulyaeva, Vladimir O. Pustylnyak
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2153-2153
Open Access | Times Cited: 7
Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets
Zihang Hong, Furong Liu, Zhanguo Zhang
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Comprehensive assessment of TECENTRIQ® and OPDIVO®: analyzing immunotherapy indications withdrawn in triple-negative breast cancer and hepatocellular carcinoma
Ghazaal Roozitalab, Behnaz Abedi, Saber İmani, et al.
Cancer and Metastasis Reviews (2024) Vol. 43, Iss. 3, pp. 889-918
Closed Access | Times Cited: 5
The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies
Jiahua Liu, Runzi Zheng, Yanghuan Zhang, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2640-2640
Open Access | Times Cited: 10
Expression levels of STAT3, and protein levels of IL‑6 and sPD‑L1 in different pathological characteristics of endometrial adenocarcinomas
Chunxing Ma, Ying He, Jing Wang, et al.
Oncology Letters (2025) Vol. 29, Iss. 3
Open Access
Pharmacological targeting of PD-L1/PD-1 signaling in gynecological cancers
Ammad Ahmad Farooqı, Gürkan Özbey, Sundas Fayyaz, et al.
Postępy Higieny i Medycyny Doświadczalnej (2025) Vol. 79, Iss. 1, pp. 25-34
Open Access
SPOP/NOLC1/B4GALT1 signaling axis enhances paclitaxel resistance in endometrial cancer by inducing O-dysglycosylation
Fengguang Zhai, Yuxuan Li, Jingfei Zheng, et al.
Oncogene (2025)
Closed Access
Matrix gla protein mediates CD8+ T-cell exhaustion to facilitate immune evasion in intrahepatic cholangiocarcinoma
Xiaohan Cao, Stephan Lang, Yulei Xie, et al.
CytoJournal (2025) Vol. 22, pp. 41-41
Open Access
Immune microenvironment and molecular mechanisms in endometrial cancer: implications for resistance and innovative treatments
Yijia Chen, Lai Jiang, Lanyue Zhang, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
miR‐186‐5p Down‐Regulates PD‐L1 Level in Acute Myeloid Leukemia Cells and Inhibits Tumorigenesis and Immune Escape
Cheng Lian, Yanhui Liu, Ping-Chong Lei
Journal of Biochemical and Molecular Toxicology (2025) Vol. 39, Iss. 5
Closed Access
The role of DDIT3 in modulating proliferation and tamoxifen resistance in luminal A subtype breast cancer through the DDIT3-IRF1 axis
Guoqing Huang, Dandan Wang, Jiaying Xue
Biochemical and Biophysical Research Communications (2025) Vol. 769, pp. 151922-151922
Closed Access
SPOP point mutations regulate substrate preference and affect its function
Yanran Deng, Wenhao Ding, Kaize Ma, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 2
Open Access | Times Cited: 3
Improving the Efficacy of Common Cancer Treatments via Targeted Therapeutics towards the Tumour and Its Microenvironment
Daniel Cecchi, Nolan Jackson, Wayne Beckham, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 175-175
Open Access | Times Cited: 2
Low Serum Apolipoprotein A1 Levels Impair Antitumor Immunity of CD8+ T Cells via the HIF-1α–Glycolysis Pathway
Qiaoying Lv, Tong Su, Wei Liu, et al.
Cancer Immunology Research (2024) Vol. 12, Iss. 8, pp. 1058-1073
Closed Access | Times Cited: 2
SPOP targets the immune transcription factor IRF1 for proteasomal degradation
Irene Schwartz, Milica Vunjak, Valentina Budroni, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 4
Opposing Roles of SPOP Mutations in Human Prostate and Endometrial Cancers
Ludimila Cavalcante, Sachin Kumar Deshmukh, Jennifer R. Ribeiro, et al.
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 4
Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions
Xinyang Li, Meng Wu, Jie Lu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 2, pp. 189084-189084
Closed Access | Times Cited: 1
Nur77-IRF1 axis inhibits esophageal squamous cell carcinoma growth and improves anti-PD-1 treatment efficacy
Huanying Shi, Lu Chen, Tianxiao Wang, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 1
RNF26 up-regulates PD-L1 to regulate the cancer immune response in ccRCC
Weigang Ren, Jing Li, R Zeng, et al.
Biocell (2024) Vol. 48, Iss. 9, pp. 1323-1330
Open Access | Times Cited: 1
Differential Impact of SPOP Mutation in Prostate and Endometrial Cancers
Georges Gebrael, Zeynep Büşra Zengin, Umang Swami
JCO Precision Oncology (2023), Iss. 7
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top